SOCIETY FOR MELANOMA RESEARCH (EIN 810638484) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Principal Officer

ELIZABETH PATTON

Tax Period

2024-01-01 to 2024-12-31

SOCIETY FOR MELANOMA RESEARCH, founded in 2003, is a small nonprofit in the Medical Research sector that reported $830K in total revenue in fiscal year 2024. Revenue grew 12% year-over-year, indicating healthy expansion. Net assets of $2.4M represent 35 months of operating reserves.

Mission

TO UNIFY THE FIELD BY INCREASING COMMUNICATION AMONG RESEARCHERS AND BUILDING BRIDGES OF COLLABORATION BETWEEN BASIC, TRANSLATIONAL, AND CLINICAL INVESTIGATORS

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $466,625

Program Service Revenue $316,464

Investment Income $46,514

Other Revenue $0

TOTAL REVENUE $829,603

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $31,808

Program Expenses $731,858

Other Expenses $820,594

TOTAL EXPENSES $851,682

Year-over-Year Comparison

	2024	2023	Change
Revenue	$829,603	$738,139	+0.1%
Expenses	$851,682	$1,085,772	-0.2%
Net Income	$-22,079	$-347,633	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
MICHAEL DAVIES MD PHD	PAST PRESIDENT	002.00	Officer Director	$0	$0	$0
ELIZABETH PATTON PHD	PRESIDENT	002.00	Officer Director	$0	$0	$0
RICHARD WHITE MD PHD	VICE PRESIDENT	002.00	Officer Director	$0	$0	$0
SHERI HOLMEN PHD	TREASURER STEERING COMM	002.00	Officer Director	$0	$0	$0
ANDREW APLIN PHD	SECRETARY	002.00	Officer Director	$0	$0	$0
CORINE BERTOLOTTO	STEERING COMM	000.50	Director	$0	$0	$0
CHRIS MARINE	STEERING COMM	000.50	Director	$0	$0	$0
CARLA DANIELA ROBLES ESPINOZA	STEERING COMM	000.50	Director	$0	$0	$0
JENNIFER MCQUADE	STEERING COMM	000.50	Director	$0	$0	$0
ALLISON BETOF WARNER	STEERING COMM	000.50	Director	$0	$0	$0
CARMIT LEVY	STEERING COMM	000.50	Director	$0	$0	$0
FLORIN KARRRETH	STEERING COMM	000.50	Director	$0	$0	$0
JESSIE VILLANUEVA PHD	STEERING COMM	000.50	Director	$0	$0	$0
NIKOLAS HAAS MD PHD	STEERING COMM	000.50	Director	$0	$0	$0
JANICE MEHNERT MD	STEERING COMM	000.50	Director	$0	$0	$0
MARIE WEBSTER PHD	STEERING COMM	000.50	Director	$0	$0	$0
ALEX MENZIES PHD	STEERING COMM	000.50	Director	$0	$0	$0
VITO REBECCA PHD	STEERING COMM	000.50	Director	$0	$0	$0
VICTORIA SANZ-MORENO	STEERING COMM	000.50	Director	$0	$0	$0
INES SILVA	STEERING COMM	000.50	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$829,603	$851,682	$2,464,920	$-22,079
2023	$738,139	$1,085,772	$2,684,018	$-347,633
2022	$630,982	$629,716	$2,608,749	$1,266
2021	$368,576	$335,231	$2,765,430	$33,345
2020	$116,444	$237,209	$2,733,147	$-120,765
2019	$1,052,470	$757,969	$3,174,356	$294,501
2018	$1,091,213	$830,718	$2,509,159	$260,495

SOCIETY FOR MELANOMA RESEARCH